About Enhancer
| Enhancer ID: | E_01_0738 |
| Species: | human |
| Position : | chr9:81580913-81582913   |
| Biosample name: | |
| Experiment class : | High+Lowthroughput |
| Enhancer type: | Enhancer |
| Disease: | Malignant neoplasm, spindle cell carcinoma of the lung |
| Pubmed ID: | 30170702 |
| Enhancer experiment: | RT-PCR, immunofluorescence light staining, fluorescence in situ hybridization (FISH) |
| Enhancer experiment description: | 5 Recently, IHC labelling for the transducin-like enhancer of split 1 (TLE1) has been proposed as a marker for diagnosis of synovial sarcoma. |
About Target gene
| Target gene : | -- |
| Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
| Less strong evidence: | RNA-Seq |
| Target gene experiment description: | 5 Recently, IHC labelling for the transducin-like enhancer of split 1 (TLE1) has been proposed as a marker for diagnosis of synovial sarcoma. |
About TF
| TF name : | TLE1 |
| TF experiment: | RT-PCR,???????,??????(FISH) |
| TF experiment description: | 5 Recently, IHC labelling for the transducin-like enhancer of split 1 (TLE1) has been proposed as a marker for diagnosis of synovial sarcoma. |
About Function
| Enhancer function : | 5 Recently, IHC labelling for the transducin-like enhancer of split 1 (TLE1) has been proposed as a marker for diagnosis of synovial sarcoma. |
| Enhancer function experiment: | Immunohistochemical staining |
| Enhancer function experiment description: |
5 Recently, IHC labelling for the transducin-like enhancer of split 1 (TLE1) has been proposed as a marker for diagnosis of synovial sarcoma. |
About SNP
| SNP ID: | -- |
Upstream Pathway Annotation of TF
Enhancer associated network
The number on yellow line represents the distance between enhancer and
target gene